Registry for health care research and quality assurance in private oncological practices
Recruiting
- Conditions
- oncological and hematological diseasesC00-D48Neoplasms
- Registration Number
- DRKS00004818
- Lead Sponsor
- rgb Onkologisches Management GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35000
Inclusion Criteria
Patient with confirmed oncological / hematological diagnosis
- At least one oncological treatment
- Beginning of documented therapy must not be longer than 10 months.
- Declaration of consent
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective is the acquisition and representation of real-life treatment in the outpatient sector. Recorded variables are defined in the common single oncological basic data set of ADT /GEKID. Additionally, data of therapy regime and its change over time is collected. The entire therapy course of a Patient will be collected from diagnosis until death or for a five year period in adjuvant therapies each patient history including all therapies of a patient.<br>The following epidemiological surveys should be specified ubiquitously:<br>- Relative survival of cancer patients in Germany<br>- Penetration guideline-based therapies in oncology outpatient practice<br>- Definition of reference- or metadata<br>Furthermore, the possibility of defining reference intervals for measures (quality indicators) that could be used as the basis for quality management systems should be analyzed.<br>
- Secondary Outcome Measures
Name Time Method not relevant